AAAAAA
Results: 1-25/91
Authors:
CLIFFE KA
TAVENER SJ
WILKE H
Citation: Ka. Cliffe et al., CONVECTIVE EFFECTS ON A PROPAGATING REACTION FRONT, Physics of fluids, 10(3), 1998, pp. 730-741
Authors:
STRUMBERG D
ERHARD J
HARSTRICK A
KLAASSEN U
MULLER C
EBERHARDT W
WILKE H
SEEBER S
Citation: D. Strumberg et al., PHASE-I STUDY OF A WEEKLY 1 H INFUSION OF PACLITAXEL IN PATIENTS WITHUNRESECTABLE HEPATOCELLULAR-CARCINOMA, European journal of cancer, 34(8), 1998, pp. 1290-1292
Authors:
STAHL M
VANHOEFER U
STUSCHKE M
WALZ MK
MULLER C
WILKE H
Citation: M. Stahl et al., PREOPERATIVE SEQUENTIAL CHEMOTHERAPY AND RADIOCHEMOTHERAPY IN LOCALLYADVANCED CARCINOMAS OF THE LOWER ESOPHAGUS AND GASTROESOPHAGEAL JUNCTION, European journal of cancer, 34(5), 1998, pp. 668-673
Authors:
HARSTRICK A
GONZALES A
SCHLEUCHER N
VANHOEFER U
LU K
FORMENTO JL
MILANO G
WILKE H
SEEBER S
RUSTUM Y
Citation: A. Harstrick et al., COMPARISON BETWEEN SHORT OR LONG EXPOSURE TO 5-FLUOROURACIL IN HUMAN GASTRIC AND COLON-CANCER CELL-LINES - BIOCHEMICAL-MECHANISM OF RESISTANCE, Anti-cancer drugs, 9(7), 1998, pp. 625-634
Authors:
KLAASSEN U
HARSTRICK A
STRUMBERG D
WILKE H
SEEBER S
Citation: U. Klaassen et al., PACLITAXEL PLUS IFOSFAMIDE IN ADVANCED OVARIAN-CANCER - RESULTS OF A PHASE-I STUDY, Anti-cancer drugs, 9(4), 1998, pp. 359-361
Authors:
KLAASSEN U
WILKE H
WEYHOFEN R
HARSTRICK A
EBERHARDT W
MULLER C
KORN M
HANSKE M
DIERGARTEN K
SEEBER S
Citation: U. Klaassen et al., PHASE-II STUDY WITH CISPLATIN AND PACLITAXEL IN COMBINATION WITH WEEKLY HIGH-DOSE 24 H INFUSIONAL 5-FLUOROURACIL LEUCOVORIN FOR FIRST-LINE TREATMENT OF METASTATIC BREAST-CANCER/, Anti-cancer drugs, 9(3), 1998, pp. 203-207
Authors:
HARSTRICK A
MAYER S
HILGER R
MULLER C
DOHMEN D
KLOPPEL R
VANHOEFER U
SCHEULEN ME
WILKE H
SEEBER S
Citation: A. Harstrick et al., COMBINATION THERAPY WITH INFUSIONAL 5-FU AND TOMUDEX FOR PATIENTS (PTS) WITH ADVANCED COLORECTAL-CANCER - A PHASE-I STUDY, Annals of oncology, 9, 1998, pp. 170-170
Authors:
KOHNE C
THUSSPATIENCE P
CATANE R",KLEIN,"PERETZ T
DUCREUX NM
WILKE H
JACQUES C
Citation: C. Kohne et al., A PHASE-II TRIAL OF CPT-11 IN PATIENTS (PTS) WITH ADVANCED GASTRIC-CARCINOMA (AGC), Annals of oncology, 9, 1998, pp. 219-219
Authors:
WILKE H
VANHOEFER U
HARSTRICK A
ACHTERRATH W
PREUSSER P
CLEMENS MR
THIEL E
FLASSHOVE M
FINK U
SEEBER S
Citation: H. Wilke et al., PHASE-II STUDY OF DOCETAXEL (D) AS SALVAGE CHEMOTHERAPY IN PATIENTS WITH ADVANCED GASTRIC-CANCER, Annals of oncology, 9, 1998, pp. 246-246
Authors:
MAYER S
HARSTRICK A
MULLER C
DOHMEN D
HILGER R
SCHEULEN ME
WILKE H
SEEBER S
Citation: S. Mayer et al., PHASE-I STUDY OF TOMUDEX COMBINED WITH PROTRACTED INFUSION OF 5-FU INPATIENTS (PTS) WITH METASTATIC COLORECTAL-CANCER, Annals of oncology, 9, 1998, pp. 633-633
Authors:
KLAASSEN U
WILKE H
HARSTRICK A
PARI CP
STRUMBERG D
NEWMANN K
EBERHARDT W
ACHTERRATH W
LENAZ L
SEEBER S
Citation: U. Klaassen et al., PACLITAXEL IN COMBINATION WITH WEEKLY 24-HOUR INFUSIONAL 5-FLUOROURACIL PLUS LEUCOVORIN IN THE 2ND-LINE TREATMENT OF METASTATIC BREAST-CANCER - RESULTS OF A PHASE-II STUDY, Annals of oncology, 9(1), 1998, pp. 45-50
Authors:
KLAASSEN U
WILKE H
HARSTRICK A
SEEBER S
Citation: U. Klaassen et al., FLUOROURACIL-BASED COMBINATIONS IN THE TREATMENT OF METASTATIC BREAST-CANCER, Oncology, 12(1), 1998, pp. 31-35
Authors:
KOHNE CH
SCHOFFSKI P
WILKE H
KAUFER C
ANDREESEN R
OHL U
KLAASEN U
WESTERHAUSEN M
HIDDEMANN W
SCHOTT G
HARSTICK A
BADE J
HORSTER A
SCHUBERT U
HECKER H
DORKEN B
SCHMOLL HJ
Citation: Ch. Kohne et al., EFFECTIVE BIOMODULATION BY LEUCOVORIN OF HIGH-DOSE INFUSION FLUOROURACIL GIVEN AS A WEEKLY 24-HOUR INFUSION - RESULTS OF A RANDOMIZED TRIALIN PATIENTS WITH ADVANCED COLORECTAL-CANCER, Journal of clinical oncology, 16(2), 1998, pp. 418-426
Authors:
EBERHARDT W
WILKE H
STAMATIS G
STUSCHKE M
HARSTRICK A
MENKER H
KRAUSE B
MUELLER MR
STAHL M
FLASSHOVE M
BUDACH V
GRESCHUCHNA D
KONIETZKO N
SACK H
SEEBER S
Citation: W. Eberhardt et al., PREOPERATIVE CHEMOTHERAPY FOLLOWED BY CONCURRENT CHEMORADIATION THERAPY BASED ON HYPERFRACTIONATED ACCELERATED RADIOTHERAPY AND DEFINITIVE SURGERY IN LOCALLY ADVANCED NON-SMALL-CELL LUNG-CANCER - MATURE RESULTS OF A PHASE-II TRIAL, Journal of clinical oncology, 16(2), 1998, pp. 622-634
Authors:
KOCK HJ
PIETSCH M
KRAUSE U
WILKE H
EIGLER FW
Citation: Hj. Kock et al., IMPLANTABLE VASCULAR ACCESS SYSTEMS - EXPERIENCE IN 1500 PATIENTS WITH TOTALLY IMPLANTED CENTRAL VENOUS PORT SYSTEMS, World journal of surgery, 22(1), 1998, pp. 12-16
Authors:
WIT A
WILKE H
Citation: A. Wit et H. Wilke, PUBLIC GOOD PROVISION UNDER ENVIRONMENTAL AND SOCIAL UNCERTAINTY, European journal of social psychology, 28(2), 1998, pp. 249-256
Authors:
ARDILL J
FLINT S
CHONG G
WILKE H
Citation: J. Ardill et al., SEQUENCE STRATIGRAPHY OF THE MESOZOIC DOMEYKO BASIN, NORTHERN CHILE, Journal of the Geological Society, 155, 1998, pp. 71-88
Authors:
MEYER HJ
JAHNE J
MOSSINGER E
WILKE H
Citation: Hj. Meyer et al., IMPORTANCE OF SURGERY IN THE TREATMENT OF NON-HODGKINS-LYMPHOMA OF THE STOMACH, European journal of cancer, 33, 1997, pp. 1216-1216
Authors:
HEINEMANN V
WILKE H
POSSINGER K
MERGENTHALER K
CLEMENS M
KONIG HJ
ILLIGER HJ
LACKHOFF A
BLATTER J
SCHALLHORN A
FINK U
Citation: V. Heinemann et al., ACTIVITY AND TOLERABILITY OF GEMCITABINE PLUS CISPLATIN IN ADVANCED METASTATIC PANCREATIC-CARCINOMA, European journal of cancer, 33, 1997, pp. 1240-1240
Authors:
KOHNE CH
HARSTRICK A
HIDDEMANN W
SCHOFFSKI P
WILKE H
BOKEMEYER C
DORKEN B
SCHMOLL HJ
Citation: Ch. Kohne et al., MODULATION OF 5-FLUOROURACIL WITH METHOTREXATE AND LOW-DOSE N-(PHOSPHONACETYL)-1-ASPARTATE IN PATIENTS WITH ADVANCED COLORECTAL-CANCER - RESULTS OF A PHASE-II STUDY, European journal of cancer, 33(11), 1997, pp. 1896-1899
Authors:
HARSTRICK A
VANHOEFER U
HEIDEMANN A
DRUYEN H
WILKE H
SEEBER S
Citation: A. Harstrick et al., DRUG-INTERACTIONS OF 5-FLUOROURACIL WITH EITHER CISPLATIN OR LOBAPLATIN - A NEW, CLINICALLY ACTIVE PLATINUM ANALOG IN ESTABLISHED HUMAN CANCER CELL-LINES, Anti-cancer drugs, 8(4), 1997, pp. 391-395
Authors:
STRUMBERG D
HARSTRICK A
KLAASSEN U
MULLER C
EBERHARDT W
KERN MW
WILKE H
SEEBER S
Citation: D. Strumberg et al., PHASE-II TRIAL OF CONTINUOUS ORAL TROFOSFAMIDE IN PATIENTS WITH ADVANCED COLORECTAL-CANCER REFRACTORY TO 5-FLUOROURACIL, Anti-cancer drugs, 8(3), 1997, pp. 293-295
Authors:
WILKE H
Citation: H. Wilke, AN INTERNATIONAL, MULTIDISCIPLINARY APPROACH TO THE MANAGEMENT OF ADVANCED COLORECTAL-CANCER, Anti-cancer drugs, 8, 1997, pp. 27-31
Authors:
HARSTRICK A
KOHNE CH
HIDDEMANN W
PREUSSER P
STRUMBERG D
BERNS T
SEEBER S
WILKE H
SCHMOLL HJ
Citation: A. Harstrick et al., MODULATION OF 5-FLUOROURACIL WITH METHOTREXATE AND LOW-DOSE N-(PHOSPHONACETYL)-L-ASPARTATE (PALA) IS INACTIVE IN ADVANCED PANCREATIC-CARCINOMA, Annals of oncology, 8(9), 1997, pp. 917-918
Authors:
VANDIJK E
WILKE H
Citation: E. Vandijk et H. Wilke, IS IT MINE OR IS IT OURS - FRAMING PROPERTY-RIGHTS AND DECISION-MAKING IN SOCIAL DILEMMAS, Organizational behavior and human decision processes, 71(2), 1997, pp. 195-209